graduation at Ciências Biológicas from Universidade Estadual Paulista "Julio de Mesquita Filho" (2007), master's at Patologia (Capes 5) from Faculdade de Medicina de Botucatu/ Unesp (2010) and doctorate at Patologia (Capes 5) from Faculdade de Medicina de Botucatu/ Unesp (2014). Has experience in Immunology, acting on the following subjects: carcinoma espinocelular de cabeça e pescoço, hormônios, macrófagos, dermatophytosis experimental and tumor de ehrlich. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Head and neck squamous cell carcinoma (HNSCC) is currently the sixth in ranking of malignancies in the world and frequently the patients suffer with tumor recurrence and metastasis. Highlighted as the main responsible for metastases, the specific group of cancer stem cells, are known for their high rates of cellular proliferation and self-renewal. In previous studies of the group, the tre…
The senescence is a tumoral suppression mechanism, where tumoral cells are unable to proliferate and are easily eliminated by immune system. Nowadays the induction of senescence by therapy represents a new functional target that may improve the therapy against cancer. Also, the Ganoderma lucidum (GL) edible mushroom has been widely used since ancient times as an auxiliary tool in human li…
The mushroom Ganoderma lucidum (GL) has been widely used in Eastern countries since ancient times as a suplementary in the longevity and treatment of human diseases, among them cancer. The GL extracts have different aims in tumor lines acting in different ways due to specific components such as, polysaccharides, acting mainly on inflammatory and antitumor responses. Among the various tumo…
(Only some records are available in English at this moment)
We have observed that treatment of DC with low concentration of some anti-neoplasic agents, is able to upregulate DC functions and phenotype, as well as increase the susceptibility of tumor cells to specific cytotoxic T lymphocytes. Based on this, we analyzed whether the in vivo combination of low-dose chemotherapy and DC vaccine would be able to increase the immune response to the murine…
| 6 / 5 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 7 / 6 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID